Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia

Acute myeloid leukemia (AML) is a heterogeneous hematopoietic malignancy originated from leukemia stem cells (LSC). Emerging evidence suggests T‐cell immunoglobulin mucin‐3(Tim3) as surface marker for LSC. However, the clinical significance and biology of Tim‐3 in AML remain to be determined, especi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhengwei, Ou, Jiawang, Liu, Nannan, Wang, Zhixiang, Chen, Junjie, Cai, Zihong, Liu, Xiaoli, Yu, Xiao, Dai, Min, Zhou, Hongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134367/
https://www.ncbi.nlm.nih.gov/pubmed/36545697
http://dx.doi.org/10.1002/cam4.5549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134367/
https://www.ncbi.nlm.nih.gov/pubmed/36545697
http://dx.doi.org/10.1002/cam4.5549

Ejemplares similares